论文部分内容阅读
目的:探讨血清ES和CYFRA21-1在肺癌患者血清中的水平及其在预后上的意义。方法:分别用电化学发光免疫学分析法和ELISA法对96例肺癌患者化疗前后及100例健康人血清中的ES和CYFRA21-1含量进行测定。结果:肺癌患者血清中的ES和CYFRA21-1水平明显高于健康对照组,化疗后两者水平均显不同程度的下降。结论:血清ES和CYFRA21-1的测定对肺癌患者化疗后的病情评估预后判断有一定的临床意义。
Objective: To investigate the serum levels of ES and CYFRA21-1 in patients with lung cancer and their prognostic significance. Methods: The levels of ES and CYFRA21-1 in serum of 96 patients with lung cancer before and after chemotherapy and 100 healthy people were measured by electrochemiluminescence immunoassay and ELISA, respectively. Results: Serum levels of ES and CYFRA21-1 in patients with lung cancer were significantly higher than those in healthy controls. The levels of ES and CYFRA21-1 in patients with lung cancer were significantly decreased after chemotherapy. Conclusion: The determination of serum ES and CYFRA21-1 has some clinical significance in the prognosis evaluation of patients with lung cancer after chemotherapy.